Stockreport

Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase [TheStreet.com]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF SEATTLE April 15, 2026 /PRNewswire/ -- Wayfinder Biosciences, a biotechnology company using small molecules to target undruggable proteins at the RNA level, today annou [Read more]